COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

CBD (Cannabidiol) and CANCER - Recent Literature reviewed - which cancers might benefit from CBD or CBD Oil?

William Makis's avatar
William Makis
Apr 20, 2024
∙ Paid
Does CBD Oil Expire? How to Check and Whether It's Safe

Paper Reviewed:

  • (2022 Feb, Kylie O’Brien) - Cannabidiol (CBD) in Cancer Management

  • (2023 May, Miranda-Massari et al) - CBD as a Physiological Modulator for Cancer

  • (2022 May, Heider et al) - Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

  • (2023 Nov, Smith et al) - Full spectrum cannabidiol oil reduces breast cancer cell viability and expression of epidermal growth factor receptor

  • (2020 Oct, Seltzer et al) - Cannabidiol (CBD) as a Promising Anti-Cancer Drug

  • (2019 Oct, Likar et al) - Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature

User's avatar

Continue reading this post for free, courtesy of William Makis.

Or purchase a paid subscription.
© 2026 William Makis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture